Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 12.63 is 33% above its 5-year average of 9.48, around the middle of its 5-year range (5.06–16.19).
As of the fiscal period ended Tuesday, June 30, 2026. 7.17% above its 12-month average of 11.78.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 12.63.
QUICK RATIO (ACID-TEST)
12.63
QUICK RATIO (ACID-TEST) AVG TTM
11.78
QUICK RATIO (ACID-TEST) AVG 3Y
10.03
QUICK RATIO (ACID-TEST) AVG 5Y
9.48
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
+7.17%
CURRENT VS 3Y AVG
+25.90%
CURRENT VS 5Y AVG
+33.17%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
2.99
median of 571 covered companies
CURRENT VS SECTOR MEDIAN
+322.33%
vs the sector median at left
AbCellera Biologics Inc.
Market Cap
$4.16B
Quick Ratio (Acid-Test)
12.63
TTM Avg
11.78
3Y Avg
10.03
5Y Avg
9.48
Market Cap
$4.30B
Quick Ratio (Acid-Test)
16.24
TTM Avg
19.89
3Y Avg
20.20
5Y Avg
22.94
Market Cap
$3.97B
Quick Ratio (Acid-Test)
1.21
TTM Avg
1.33
3Y Avg
1.21
5Y Avg
1.93
Market Cap
$4.33B
Quick Ratio (Acid-Test)
5.08
TTM Avg
3.83
3Y Avg
4.06
5Y Avg
4.06
Market Cap
$4.41B
Quick Ratio (Acid-Test)
0.66
TTM Avg
0.63
3Y Avg
0.81
5Y Avg
1.13
Market Cap
$4.56B
Quick Ratio (Acid-Test)
4.68
TTM Avg
3.02
3Y Avg
3.88
5Y Avg
4.28
Market Cap
$4.67B
Quick Ratio (Acid-Test)
6.95
TTM Avg
6.77
3Y Avg
6.23
5Y Avg
10.87
Market Cap
$4.68B
Quick Ratio (Acid-Test)
1.38
TTM Avg
1.51
3Y Avg
1.37
5Y Avg
1.40
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| AbCellera Biologics Inc. (ABCL) | $4.16B | 12.63 | 11.78 | 10.03 | 9.48 |
| LivaNova PLC (LIVN)vs › | $4.16B | 1.21 | 1.83 | 2.18 | 1.91 |
| Edgewise Therapeutics, Inc. (EWTX)vs › | $4.30B | 16.24 | 19.89 | 20.20 | 22.94 |
| ICU Medical, Inc. (ICUI)vs › | $3.97B | 1.21 | 1.33 | 1.21 | 1.93 |
| Heartflow, Inc. Common Stock (HTFL)vs › | $4.33B | 5.08 | 3.83 | 4.06 | 4.06 |
| Indivior Pharmaceuticals Inc (INDV)vs › | $4.41B | 0.66 | 0.63 | 0.81 | 1.13 |
| Adaptive Biotechnologies Corporation (ADPT)vs › | $4.56B | 4.68 | 3.02 | 3.88 | 4.28 |
| Definium Therapeutics, Inc. (DFTX)vs › | $4.67B | 6.95 | 6.77 | 6.23 | 10.87 |
| LifeStance Health Group, Inc. (LFST)vs › | $4.68B | 1.38 | 1.51 | 1.37 | 1.40 |
| Dianthus Therapeutics, Inc. (DNTH)vs › | $4.72B | 26.10 | 14.27 | 14.23 | 14.47 |
Quick Ratio
12.63
Excludes inventory
Current Ratio
12.77
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 12.63 |
| 2026-03-31 | 13.89 |
| 2025-12-31 | 11.23 |
| 2025-09-30 | 10.10 |
| 2025-06-30 | 11.07 |
| 2025-03-31 | 10.15 |
| 2024-12-31 | 9.81 |
| 2024-09-30 | 9.34 |
| 2024-06-30 | 10.96 |
| 2024-03-31 | 7.75 |
| 2023-12-31 | 7.32 |
| 2023-09-30 | 8.33 |
| 2023-06-30 | 7.82 |
| 2023-03-31 | 10.48 |
| 2022-12-31 | 8.65 |
| 2022-09-30 | 9.62 |
| 2022-06-30 | 5.06 |
| 2022-03-31 | 5.39 |
| 2021-12-31 | 7.69 |
| 2021-09-30 | 16.19 |
| 2021-06-30 | 12.37 |
| 2021-03-31 | 10.26 |
| 2020-12-31 | 7.85 |
| 2020-09-30 | 5.62 |
| 2020-06-30 | 7.04 |
| 2020-03-31 | 0.00 |
| 2019-12-31 | 1.58 |
| 2019-09-30 | 0.00 |
| 2019-06-30 | 0.00 |
| 2019-03-31 | 0.00 |
